The DOI matches its Crossref record.
Preclinical prediction of Alzheimer's disease using SPECT
Abstract
BACKGROUND: Regional cerebral perfusion measured by single photon emission computed tomography (SPECT) was examined as a preclinical predictor of the development of Alzheimer's disease (AD). METHODS: Singular value decomposition was used to produce 20 SPECT factors (known as vectors) (n=152). Vector scores were then computed for four groups (n=136), differing in cognitive status: Group 1--normal controls at both baseline and follow-up; Group 2--subjects with "questionable" AD at both baseline and follow-up; Group 3--subjects with questionable AD at baseline who converted to AD on follow-up (Converters); Group 4--subjects with AD at baseline. All SPECT data in the analyses were gathered at baseline. RESULTS: The four groups could be distinguished on the basis of their baseline SPECT data (p < or = 0.00005; hit rate=83%). Regional decreases in perfusion were most prominent among Converters in the hippocampal-amygdaloid complex, the posterior cingulate, the anterior thalamus, and the anterior cingulate. Inclusion of apolipoprotein E status did not significantly improve the discrimination. CONCLUSIONS: SPECT data gathered and analyzed in this manner may be useful as one aspect of the preclinical prediction of AD. Three of the four brain regions important for discriminating Converters from normal controls involve a distributed brain network pertaining to memory, suggesting that this network may be selectively affected in the earliest stages of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced size or glucose metabolism (METglu) in the EC (10), Hip (11–16), temporal neocortex (17–20), and posterior cingulate gyrus (16) have been shown to predict the MCI conversion to AD.”
From Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET) (2001) · cites this paper as [16]
In the citing paper
“The recent SPECT study by Johnson et al. (16) demonstrated that reduced perfusion of the Hip and posterior cingulate gyrus predicted AD.”
From Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET) (2001) · cites this paper as [16]
Citations
Cited by
Sorted by citations
Items 401–467 of 467
AtlasMorph: Learning conditional deformable templates for brain MRI
Rakic, M., Hoopes, A., Abulnaga, S. M., Sabuncu, M. R., Guttag, J. V., & Dalca, A. V. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103893 · Cited by 1
“This template was built using ANTs on 39 subjects from Buckner40 data [1, 47, 72].”
Chapter 15 Advances in Neuroimaging
Scheltens, P. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70066-8 · Cited by 1
Menon, P. M., Vonsattel, J. P., & Jolles, P. R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1166 · Cited by 1
“The utility of 99m Tc HMPAO perfusion SPECT in staging AD has been demonstrated in several studies [69–72].”
Characteristic Diagnostic Imaging Findings in Alzheimer's Disease
Kitamura, S. (2003) · Cited by 1
Neural Correlates of Controlled Memory Processes in Questionable Alzheimer's Disease
Bastin, C., Kerrouche, N., Françoise, L., Stéphane, A., Bénédicte, G., Lemaire, C. F., Aerts, J. J., Géry, D., Collette, F., & Salmon, É. (2011) · Advances in Alzheimer's disease · doi:10.3233/978-1-60750-793-2-191 · Cited by 1
SPECT cerebral y enfermedad de Alzheimer: una revisión
Castañeda, M. S., García‐Ruiz, J. C., García, J. A. G., et al. (2000) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Computer-Based Assessment of Alzheimer’s Disease Employing fMRI and/or EEG: A Comprehensive Review
Tripoliti, E. E., Zervakis, M. E., & Fotiadis, D. I. (2014) · Neuromethods · doi:10.1007/7657_2014_70 · Cited by 1
Prediction and targeted prevention of Parkinson's and Alzheimer's diseases
Mandel, S. A., Halperin, I. J. Y., Korczyn, A. D., & Morelli, M. (2009) · Cited by 1
Tarulli, A. W. (2020) · Springer eBooks · doi:10.1007/978-3-030-55598-6_4 · Cited by 2
Mild Cognitive Impairment Neuroimaging Markers for Early Diagnosis of Dementia
Huang, C. C. (2003) · Figshare · Cited by 1
Cerebral glucose metabolic abnormality in patients with congenital scoliosis
Park, W. W., Suh, K. T., Kim, J. I., Ku, J. G., Lee, H. S., Kim, S., Kim, I., Kim, Y.-K., & Lee, J. S. (2008) · European Spine Journal · doi:10.1007/s00586-008-0682-1 · Cited by 1
“In a clinical setting, cerebral blood flow in the posterior cingulate has been shown to be correlated with the clinical severity of dementia [1], and long-term changes in the posterior cingulate cerebral blood flow could be predictive of an onset of clinical symptoms of Alzheimer disease later in life [ 14 ].”
BackgroundResting state brain activity and functional brain mapping
Xiaohu, Z., Peijun, W., & Xiaowei, T. (2007) · Progress in Natural Science Materials International · doi:10.1080/10020070708541030 · Cited by 1
Fakhri, G. N. E., Kijewski, M. F., & Moore, S. C. (2002) · 2006 IEEE Nuclear Science Symposium Conference Record · doi:10.1109/nssmic.2000.949215 · Cited by 1
Chertkow, H. M. (2002) · Cited by 1
Marcadores genéticos relacionados con el déficit cognitivo en el envejecimiento
Solé‐Padullés, C., Clemente, I. C., & David Bartrés-faz, A. (2004) · Digitum: Institutional Repository of the University of Murcia (University of Murcia) · Cited by 1
Sensitivity of SPECT for the Diagnosis of Alzheimer's Disease
Ott, B. R., & Noto, R. B. (2000) · Clinical Gerontologist · doi:10.1300/j018v22n01_07 · Cited by 1
"Espectroscopia de prótons na demência de Alzheimer e no comprometimento cognitivo"
de Souza, A. S. (2005) · doi:10.11606/t.5.2005.tde-12042006-090739 · Cited by 1
Córdova, C. A. (2005) · eScholarship (California Digital Library) · Cited by 1
Gerstenmayer, M. (2018) · theses.fr (ABES) · doi:10.70675/5aa7fd45z24caz43e9zaaadzeb1ca21e8661 · Cited by 1
Erkrankungen, die zu einer organischen psychischen Störung führen können
Wetterling, T. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57532-7_5
González, M. C. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.122909
Retinal Structural Changes in Patients with Mild Cognitive Impairment
Iordanis, D. (2015) · Clinical Medicine Research · doi:10.11648/j.cmr.s.2015040201.11
“Cerebral blood flow is also reduced in MCI patients [40], [41].”
BackgroundImaging of the Geriatric Brain
Apostolova, L. G., Fleisher, A., Drzezga, A. E., Nair, A. K., & Sabbagh, M. N. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch7
Imaging of brain structure and function: relevance to psychiatric disorders
Mamo, D. C., & Kapur, S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.005
Molecular Neuroimaging of the Dementias
Dickerson, B. C. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch19
Baron, J., Chételat, G., Desgranges, B., & Eustache, F. (2004) · Springer eBooks · doi:10.1007/978-3-642-59300-0_11
“Four studies compared converters to healthy controls using voxel-based techniques (Johnson et al. 1998; Kogure et al. 2000; Minoshima et al. 1997; Tanaka et al. 2002; De Santi et al. 2001) and consistently reported hypoperfusion/hypometabolism of the PCG region in the patient group, variably involving other areas in s…”
BackgroundResultLanzo, E. A. (2001) · TDX (Tesis Doctorals en Xarxa)
Maki, P. M., & Resnick, S. M. (2005) · Springer eBooks · doi:10.1007/3-211-27063-9_12
“These are the same regions that show hypoperfusion in individuals at increased risk for Alzheimer’s disease (Kennedy et al. 1995; Reiman et al. 1996; Johnson et al. 1998).”
BackgroundNeuroimaging Changes in Preclinical Alzheimer's Disease
Horne, N. R., & Bondi, M. W. (2003) · Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders · doi:10.1044/nnsld13.4.12
Eggermont, L. H. P. (2007) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
The contribution of magnetic resonance spectroscopy as biomarker in Alzheimer’s disease
Modrego, P. J. (2012) · Journal of Biomedical Graphics and Computing · doi:10.5430/jbgc.v3n1p66
“Published by Sciedu Press 67 follow-up period, between the following percentages: 12% per year for 4 years in comparison to 1%-2% annual for controls ([1]), 40% across 2 years ([3]), 34% over 4.”
BackgroundOscillatory brain activity in memory disorders
Osipova, D. V. (2007)
Methylene blue, spatial memory and anterior thalamic lesions relevant to amnesic disorders.
Edlin, S. M. (2011) · UC Research Repository (University of Canterbury) · doi:10.26021/5865
MRI and CSF studies in the early diagnosis of Alzheimer's
Eon, L., Lark, C. C., DeSanti, S., Zinkowski, R. P., Segal, S., Clark, C. N., DeBernardis, J. F., Lair, L. L., & Reisberg, . (2004)
A KRÓNIKUS AGYI HIPOPERFÚZIÓ SZEREPE AZ ALZHEIMER-KÓR KIALAKULÁSÁBAN
Zádori, D., Zsolt, D., Penke, B., & Datki, Z. (2007)
Nako, A., Siritho, S., Chotinaiwattarakul, W., et al. (2006) · PubMed
Tomografía por emisión de fotón único
Domínguez‐Gadea, L. (2008) · Elsevier eBooks · doi:10.1016/b978-84-458-1776-6.50006-x
Dementia and Alzheimer Disease: Evidence-Based Neuroimaging
Gutierrez, J. E., Eichinger, B., & Kantarci, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3320-0_17
Functional imaging of Alzheimer's disease
Taler, V., & Saykin, A. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.025
IMAGE REGISTRATION USING COMPUTER TECHNIQUES: APPLICATIONS ON NUCLEAR MEDICINE IMAGES
Alves, R. D. S. (2013)
10 Neuroimaging in Alzheimer Disease
Kantarci, K., & Jack, C. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7777-9_10
Dementia and Cerebrovascular Disease
Kim, S.-E., & Lee, M. (2004) · Springer eBooks · doi:10.1007/978-0-387-22530-2_11
Zerebrale Bildgebung bei Demenzen: State-of-the-Art Brain Imaging in Dementia: State-of-the-Art
Boelmans, K., & Buchert, R. (2013)
Stroke, Cognitive Function, and Alzheimer’s Disease
Jackman, K. A., Cumming, T. B., & Miller, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00011-5
Imaging CNS Disease States: Alzheimer’s Disease
Dickerson, B. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0134-7_19
“1996) and the early detection of disease state in individuals with MCI (Herholz et al. 1999; Johnson et al. 1998; Arnaiz et al. 2001; Chetelat et al. 2003).”
BackgroundCalvo, M. A. (2017) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/29463
Mondadori, C. R. A. (2006) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-163345
(1999) · Le Fil rouge. Section 1, Psychanalyse/Le Fil rouge/Le Fil rouge. Section 2, Psychanalyse et psychiatrie de l'enfant · doi:10.3917/puf.quar.1999.01.0171
Tarulli, A. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-29632-6_4
Tarulli, A. W. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933851.006
How to Diagnose an Alzheimer Disease?
Bourin, M. (2017) · Theranostics of Brain Spine & Neural Disorders · doi:10.19080/tbsnd.2017.01.555566
“Patients with Alzheimer’s disease are also distinguished from normal elderly subjects in cerebral scintigraphy by hypoperfusion in the hippocampo-tonsillar region [22], and then the cerebral hypodébit appears in the posterior parieto-temporal cortical regions bilateral.”
BackgroundVu, D.-T., Can, D.-C., Diaz, C. S., Bodelet, J., Blanc, G. E., Phan, H., Allali, G., Nguyen, V.-D., Cao, H., He, X., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.11.584383
“A full listing of ADNI investigators is available at: http://adni.loni.usc.edu/wp-content/uploads/how to apply/ADNI”
Transposición del epiplón como tratamiento neuroquirúrgico de la enfermedad de Alzheimer
Goldsmith, H. S., & Cremaschi, F. (2008) · NeuroTarget · doi:10.47924/neurotarget2008348
Endothelin-converting enzyme-2
Devi, L. A., & Gomes, I. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00057-6
Rahim, F., Khalafi, M., Davoodi, M., & Shirbandi, K. (2023) · Figshare · doi:10.6084/m9.figshare.22774337
Bellaali, Y., Šulcová, D., Salatino, A., Dricot, L., Hanseeuw, B. J., Woodard, J. L., & Ivanoiu, A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1742759
Performance evaluation of a clinical SPECT system with multifocal collimator for brain studies
Otani, T., Kunikane, Y., Takashi, S., et al. (2026) · Medical Physics · doi:10.1002/mp.70451
Aging and metabolism contribute separately to brain–body health
Farahani, A., Liu, Z.-Q., Morys, F., Moqadam, R., Zeighami, Y., Dadar, M., Dagher, A., & Mišić, B. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003856
“For instance, brain blood perfusion reduction and vascular dysregulation are linked with greater dementia risk, and can precede observable brain atrophy and clinical symptom onset of the disease by years [31–36].”
Vascular risk, functional connectivity, and episodic memory in older adults
Hartman, T., & Rochon, E. A. (2014) · Loyola eCommons (Loyola University of Chicago)
Collette, F. (2007) · ORBi (University of Liège)
Resting-state functional magnetic resonance imaging in late-life depression and dementia
Kenny, E. R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Neurology
- Published
- 1998-06
- Volume
- 50
- Issue
- 6
- Pages
- 1563-1571
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1964965688
- Cited by
- 471
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 11 · 2016: 12 · 2015: 17 · 2014: 13 · 2013: 15 · 2012: 12
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag009301-08)
- National Institute on Aging (R01-AG09301, P01AG004953)
- National Center for Research Resources (M01RR000088)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, single photon emission computed tomography, regional cerebral blood flow, singular value decomposition, posterior cingulate cortex, anterior thalamic nuclei, anterior cingulate cortex, apolipoprotein E, memory networks, cognitive decline
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cerebrovascular Circulation, Female, Forecasting, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Tomography, Emission-Computed, Single-Photon, Discriminant Analysis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review